Www.kdigo.org KDIGO Overview. Kidney Disease: Improving Global Outcomes www.kdigo.org Mission Governance Clinical Practice Guidelines Controversies Conferences.

Slides:



Advertisements
Similar presentations
The Nephrology Oral History Project
Advertisements

© 2011 Health Level Seven ® International. All Rights Reserved. HL7 and Health Level Seven are registered trademarks of Health Level Seven International.
Monday, 3rd October 2005 Presented by Louis ROMANET Chairman of ICSC Chairman of IRPAC IMPLEMENTATION OF QUALITY CONTROL ON RACING.
The world-wide epidemiology of CKD and KDIGO Norbert Lameire Em prof Medicine University Hospital Gent, Belgium.
KDIGO Clinical Practice Guideline for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease- Mineral and Bone Disorder (CKD-MBD)
What is the International Society of Behavioral Medicine (ISBM)? ISBM is a Federation of national, regionally-based or specialized scientific.
Foundation Civilization Day, Foundation Week May 8-14, 2006 Anatolia Kidney Foundation Day, May 8, 2006 Prof. Dr. Ayla SAN THE IMPORTANCE OF 9 MARCH WORLD.
James Tattersall European Best Practice Guidelines.
Criminal Organizations and Drugs Sub-Directorate
Medical Education Grand Rounds Self-Study Overview Middle States Commission on Higher Education January 13, 2010.
KDIGO Guidelines Development: Strengths and Challenges KDIGO Controversies Conference Clinical Practice Guidelines: Methodology October 12, 2007 Joseph.
AsiaCrypt Program Committee Report Chi Sung Laih Nov.30~Dec.4,2003 Taipei, Taiwan.
Strengths and challenges of the CPG development process: Canadian Society of Nephrology Marcello Tonelli MD SM Chair, CSN-CPG Committee.
Introducing The Law Firm Network June O U T L I N E Overview of The Law Firm Network Strategic Objectives Representative Success Stories.
© Lloyd’s Regional Watch Content Guide CLICK ANY BOX AMERICAS IMEA EUROPE ASIA PACIFIC.
UNESCO and Ethics Division of Ethics of Science and Technology United Nations Educational, Scientific and Cultural Organization Established Nov.1945 Hdq.
Improving Nephrology around the World March 16-18, 2004 ISN COMGAN Bellagio Conference Prevention of renal diseases in the emerging world: Toward global.
Leaders in Asset Management ISO Asset Management Systems 1 Prepared by Jim Dieter, MIAM CPPM CF NPMA Executive Vice President Director of Strategic.
REG set up: first steps… Alison Chisholm 7.40 am – 7:45 am.
Guideline Statements  27 guideline statements  Major content areas:  Immunosuppression  Graft monitoring and infections  Cardiovascular disease risk.
Nation Brands Index Culture, External Affairs and Tourism Analytical Team Helen Fogarty.
1 Ho Chi Minh City, Vietnam, July 27, 2008 Daniel Navid, Chief Executive Officer International Osteoporosis Foundation Osteoporosis and the role of IOF.
Scientific organizations that agree that humans are changing the climate  American Academy of Pediatrics  American Association for the Advancement of.
These slides were sponsored by Janssen and developed in conjunction with the BRS CKD Strategy Group, following an advisory board that was organised by.
ISBM is a Federation of national or regionally-based societies, whose goal is to serve the needs of all health-related disciplines.
OECD Review of Russian Statistics Peer Review Mission to Russia April 2012 Tim Davis Head, Global Relations, Statistics Directorate.
PRIVP Huang Overview of Successes and Challenges
Region 10 Asia-Pacific IEEE R10 Meeting, Ahmedabad, 3-4 February 2008 Janina Mazierska IEEE Asia Pacific Director
CFP ® Certification: A Global Perspective Noel Maye, CEO Financial Planning Standards Board Ltd. 22 November 2006.
International Comparison Program (ICP) Overview of 2003 Round Workshop Goals and Objectives Fred Vogel, Global Manager.
EDUNIVERSAL 2 d World Convention Cape Town October 2009.
Document Delivery Worldwide: Document Delivery Worldwide: PubMed, Loansome Doc and DOCLINE Martha R. Fishel Eve-Marie Lacroix Public Services Division.
CORPORATE WOMEN DIRECTORS INTERNATIONAL Global Summit of Women Sao Paulo, Brazil May 15, 2015 CWDI Report on Women Board Directors of 100 Largest Latin.
January 2012IHE Europe 1 INTEGRATING THE HEALTHCARE ENTERPISE Morten Bruun-Rasmussen, MEDIQ Charles Parisot, GE Healthcare, IHE International Board Vilnius,
The only prescription with unlimited refills. Regular exercise (150 minutes per week) lowers risk of developing heart disease, high blood pressure,
1 Announcing … Global broadband subscribers to 30 June 2005 Total: 176 million 115 million * 65% * choose DSL.
1 1 The AHRQ Surveys on Patient Safety Culture Setting the Standard for Patient Safety Culture Around the Globe AHRQ Annual Meeting September 19, 2011.
Chapter 15 Development of the profession of O&M around the world.
BMH CLINICAL GUIDELINES IN EUROPE. OUTLINE Background to the project Objectives The AGREE Instrument: validation process and results Outcomes.
Linda A. Bailey, JD, MHS How Regional Networks Can Support Quitlines 11/11/2011.
1 Our Open Standards Community Jerry Hubbard Executive Vice President, Business Development Petrotechnical Open Standards Consortium WITSML ™ Seminar &
Recent developments in rankings: implications for developing countries? Jamil Salmi The World Bank IREG-3 Shanghai, October 2007.
Richard Ceska, President of Cardionale, on behalf of IAS Welcome to PRAGUE Welcome to CARDIONALE.
Why is there a need for a European Association for Language Testing and Assessment? Charles Alderson, Lancaster University, Coordinator of ENLTA.
International Auditing and Assurance Standards Board ISA Implementation Monitoring Project Update Jon Grant, IAASB Task Force Chairman IAASB Board Meeting.
Global Financial Regulatory Framework Regulating International Capital Market Masters in Accountancy (MACC508)
SOA Strategic Plan Development Part II: Necessary Changes February 2015.
With Global B2B Contacts COO mailing list, you can effectively reach the COO.
Making Clinical Practice Guidelines “Better” Katrin Uhlig, MD MS Director, Guideline Development Tufts Center for Kidney Disease Guideline Development.
Metal Working Group Metals: conservation and Research - Brussels, October 2003 The ICOM-CC Metal Working Group as a promoter of research in metal.
KDIGO guidelines glomerulonephritis Dr.. Overview Rationale for requirement of guidelines KDIGO: GN Guidelines  Scope Clinical Nephrology Conferences.
Professor Julie Bernhardt x Co-Head, Stroke Division Director, AVERT Early Intervention Research Program, Australia Director, Centre of Research Excellence.
with the global Rotary family
Continents and Oceans.
ISN is a unique medical society – with a humanitarian mission
MUHC Innovation Model.
HIMSS STANDARDS INITIATIVES
The Most Visited Countries
The World Market.
Status of EQ-5D-5L Valuation Using Standardized Valuation Methodology
KDIGO Clinical Practice Guideline for Lipid Management in CKD: summary of recommendation statements and clinical approach to the patient  Christoph Wanner,
HPH Strategy Seminar Beijing, China 7 september 2013 Andrea Limbourg
Volume 94, Issue 4, Pages (October 2018)
Evidence and Outcomes in CKD
Global Commercial Agriculture
Volume 87, Issue 1, Pages (January 2015)
The International Cost Engineering Council (ICEC)
Emerging Issues and Outreach Committee
What Should a Guideline Panel Do When Evidence Is Inconclusive
Volume 83, Issue 3, Pages (March 2013)
Presentation transcript:

KDIGO Overview

Kidney Disease: Improving Global Outcomes Mission Governance Clinical Practice Guidelines Controversies Conferences Guideline Coordination Guideline Implementation Website KDIGO

Kidney Disease: Improving Global Outcomes KDIGO Mission

Kidney Disease: Improving Global Outcomes KDIGO An independently incorporated nonprofit foundation, governed by an international board, with the stated mission to: ‘Improve the care and outcomes of kidney disease patients worldwide through promoting coordination, collaboration, and integration of initiatives to develop and implement clinical practice guidelines.’

Kidney Disease: Improving Global Outcomes KDIGO Governance

Kidney Disease: Improving Global Outcomes Organizational Structure Board Board of Councelors (retired BOD members) Management: National Kidney Foundation KDIGO Workgroups - CPG Workgroups - Liaison Task Force - Implementation Task Force KDIGO Workgroups - CPG Workgroups - Liaison Task Force - Implementation Task Force Evidence review: Evidence Review Team Tufts NEMC Evidence review: Evidence Review Team Tufts NEMC Executive Committee Nominating committee Nominating committee Foundation under Belgium law

Kidney Disease: Improving Global Outcomes KDIGO Board of Directors Omar I. Abboud, MD, SUDAN Sharon Adler, MD, USA Rajiv Agarwal, USA Sharon P. Andreoli, MD, USA Robert Atkins, MD, AUSTRALIA Gavin Becker, MD, AUSTRALIA Fred Brown, MBA, USA Daniel Cattran, MD, CANADA Allan Collins, MD, USA Josef Coresh, MD, USA Ricardo Correa-Rotter, MD, MEXICO Adrian Covic, MD, ROMANIA Jonathon Craig, MD, AUSTRALIA Angel de Francisco, MD, SPAIN Paul de Jong, MD, NETHERLANDS Tilman Drüeke, MD, FRANCE Ana Figueiredo, RN, BRAZIL Mohammed Benghanem Gharbi, MD, MORROCO Gordon Guyatt, MD, CANADA Philip Halloran, MD, CANADA David Harris, MD, AUSTRALIA Enyu Imai, MD, JAPAN Co-Chairs: Kai-Uwe Eckardt, MD GERMANY Bertram Kasiske, MD USA

Kidney Disease: Improving Global Outcomes KDIGO Board of Directors Michel Jadoul, MD, BELGIUM Simon Jenkins, Patient, UK Vivekanand Jha, MD, INDIA Suhnggwon Kim, MD, KOREA Martin Kuhlmann, MD, GERMANY Nathan Levin, MD, USA Phillip K.T. Li, MD, HONG KONG Zhi-Hong Liu, MD, CHINA Pablo Massari, MD, ARGENTINA Peter McCullough, MD, USA Rafique Moosa, MD, SOUTH AFRICA Miguel C. Riella, MD, BRAZIL Bernardo Rodriguez-Iturbe, MD, VENEZUELA Robert Schrier, MD USA Hooi Lai Seong, MD, MALAYSIA Justin Silver, MD, ISRAEL Lesley Stevens, MD, USA Marcello Tonelli, CANADA Yusuke Tsukamoto, MD, JAPAN Theodor Vogels, MSW, NETHERLANDS David Wheeler, MD, UK Elena Zakharova, MD, RUSSIA

Kidney Disease: Improving Global Outcomes Executive Committee Co-chairs: Kai-Uwe Eckardt Germany Bertram KasiskeUnited States Past co-chairs:Norbert LameireBelgium Garabed EknoyanUnited States Members: Josef Coresh United States Jonathon Craig Australia Angel de FranciscoSpain Michel JadoulBelgium Nathan LevinUnited States Miguel RiellaBrazil Robert SchrierUnited States Yusuke TsukamotoJapan David WheelerUnited Kingdom

Kidney Disease: Improving Global Outcomes Clinical Practice Guidelines

Kidney Disease: Improving Global Outcomes Guiding Principles for KDIGO Guideline Development Scientific and methodological rigor Interdisciplinary approach Independence of work groups Transparency of the guideline development process

Kidney Disease: Improving Global Outcomes Quality of evidence High AStrength of recom- mendation 1 Corresponds to “strong“ in GRADE Moderate B Low C 2 Corresponds to “weak“ in GRADE Very low D e.g. (Grade 1C) or (Grade 2D) ……(8 options) Plus option to include statements that are not graded 2 components of final grade:  granularity and transparency Although quality of evidence influences strength of recommendation, no direct link “Neutral“ alphanumeric code instead of terms that may be interpreted differently Grading: The Quality of the Evidence and the Strength of the Recommendation

Kidney Disease: Improving Global Outcomes Published Clinical Practice Guidelines Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C in CKD –Published in Kidney International in April, 2008 Diagnosis, Evaluation, Prevention, and Treatment of CKD-MBD –Published in Kidney International in July, 2009 Care of Kidney Transplant Recipients –Published in the American Journal of Transplantation in October, 2009; Executive Summary published in Kidney International in December, 2009

Kidney Disease: Improving Global Outcomes Guidelines in Development Acute Kidney Injury –Chairs: John Kellum & Norbert Lameire –Anticipated Publication: June, 2011 Glomerulonephritis –Chairs: John Feehally & Dan Cattran –Anticipated Publication: August, 2011 Blood Pressure in CKD –Chairs: Gavin Becker & David Wheeler –Anticipated Publication: October, 2011

Kidney Disease: Improving Global Outcomes Guidelines in Development Anemia in CKD –Chairs: John McMurray and Patrick Parfrey –Anticipated Publication: November, 2011 CKD Classification and Treatment –Chairs: Adeera Levin and Paul Stevens –Anticipated Publication: July, 2012 Lipids in CKD –Chairs: Marcello Tonelli and Christoph Wanner –Anticipated Publication: August, 2013 Peritoneal Dialysis –Chairs: Philip Li and –Anticipated Publication: 2013

Kidney Disease: Improving Global Outcomes Controversies Conferences

Kidney Disease: Improving Global Outcomes KDIGO Controversies Conferences Drug Prescribing in Kidney Disease: Initiative for Improved Dosing (May 2010) Co-chairs: George Aronoff and Patrick Murray Cardiovascular Disease in CKD: What is it and what can we do about it? (October 2010) Co-chairs: Eberhard Ritz and Charles Herzog

Kidney Disease: Improving Global Outcomes Planned KDIGO Controversies Conferences Novel Dialysis Techniques (October 2011) Co-Chairs: Christopher Chan, Nathan Levin and Francesco Locatelli Diabetes in CKD (March 2012) Co-Chairs: Mark Molitch and Carl Mogensen

Kidney Disease: Improving Global Outcomes Guideline Coordination

Kidney Disease: Improving Global Outcomes Collaborating Guideline Groups Canadian Society of Nephrology (CSN) Guidelines Caring for Australians with Renal Impairment (CARI) Guidelines - ANZSN United Kingdom Renal Association Guidelines European Renal Best Practice (ERBP) – ERA/EDTA Kidney Disease Outcomes Quality Initiative (KDOQI) Guidelines – NKF ISN Guideline Committee

Kidney Disease: Improving Global Outcomes Guideline Coordination Liaison Task Force Global Guideline Coordination Group ISN/KDIGO Collaboration Group

Kidney Disease: Improving Global Outcomes Guideline Implementation

Kidney Disease: Improving Global Outcomes Guideline Implementation Publish Guidelines in multiple languages on KDIGO website and in regional journals Commentaries from ISN, KDOQI, ERBP, UK- RA, CARI, and CSN Develop professional education tools based on KDIGO Guidelines KDIGO Implementation Task Force

Kidney Disease: Improving Global Outcomes Implementation Task Force The KDIGO Implementation Task Force is charged with promoting awareness, dissemination, adoption and clinical integration of KDIGO Clinical Practice Guidelines locally, around the world.

Kidney Disease: Improving Global Outcomes Implementation Task Force Task Force divided into 6 regions Each Task Force Leader has designated Regional Representatives from the countries within their region There will be different approaches to guideline dissemination depending on the region and on the country Type the Presentation Title here – Type the Presentation Subtitle here

Kidney Disease: Improving Global Outcomes KDIGO Implementation Task Force LEADERREGION Yusuke Tsukamoto (Chair)Asia Pacific Michelle JosephsonNorth America Miguel RiellaLatin America Michel Jadoul Western Europe Andrzej Więcek Eastern Europe Mona Al Rukhaimi Middle East/Africa

Kidney Disease: Improving Global Outcomes Implementation Task Force Activities: Facilitate and increase the number of presentations on KDIGO guidelines at local, national, and regional meetings. Translate and submit guideline translations and executive summaries to regional journals for publication.

Kidney Disease: Improving Global Outcomes Activities: Promote integration and adoption of guidelines into residency training programs. Assist in developing commentaries / editorials on KDIGO Guidelines for publication in regional journals. Communicate with regional healthcare administrators to promote adoption of practice guidelines. Implementation Task Force

Kidney Disease: Improving Global Outcomes KDIGO Website

Kidney Disease: Improving Global Outcomes Website Resources KDIGO Guidelines: –All published guidelines available –Recommendations translated into multiple languages –Slide presentations Reports from Controversies Conferences –Published position statements –Conference presentations

Kidney Disease: Improving Global Outcomes Website Resources Global Nephrology Guideline Database: –Guideline Overviews by Organization –Guideline Summaries by Clinical Topic

Thank you